Doi Y - Search Results

1

High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.

Doi Y, Sasaki D, Terada C, Mori S, Tsuruda K, Matsuo E, Miyazaki Y, Nagai K, Hasegawa H, Yanagihara K, Yamada Y, Kamihira S. Doi Y, et al. Int J Hematol. 2009 Jul;90(1):37-43. doi: 10.1007/s12185-009-0337-y. Epub 2009 May 23. Int J Hematol. 2009. PMID: 19466505

2

Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.

Itonaga H, Tsushima H, Hata T, Matsuo E, Imanishi D, Imaizumi Y, Kawaguchi Y, Fukushima T, Doi Y, Mori S, Kamihira S, Tomonaga M, Miyazaki Y. Itonaga H, et al. Among authors: doi y. Int J Hematol. 2012 Feb;95(2):209-13. doi: 10.1007/s12185-012-1005-1. Epub 2012 Jan 20. Int J Hematol. 2012. PMID: 22262141 Free article.

3

Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL.

Kamihira S, Iwanaga M, Doi Y, Sasaki D, Mori S, Tsurda K, Nagai K, Uno N, Hasegawa H, Yanagihara K, Morinaga Y, Tsukasaki K, Taniguchi H. Kamihira S, et al. Among authors: doi y. Int J Hematol. 2012 Apr;95(4):399-408. doi: 10.1007/s12185-012-1020-2. Epub 2012 Mar 28. Int J Hematol. 2012. PMID: 22453915

4

Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group.

Itonaga H, Tsushima H, Imanishi D, Hata T, Doi Y, Mori S, Sasaki D, Hasegawa H, Matsuo E, Nakashima J, Kato T, Horai M, Taguchi M, Matsuo M, Taniguchi H, Makiyama J, Sato S, Horio K, Ando K, Moriwaki Y, Sawayama Y, Ogawa D, Yamasaki R, Takasaki Y, Imaizumi Y, Taguchi J, Kawaguchi Y, Yoshida S, Joh T, Moriuchi Y, Nonaka H, Soda H, Fukushima T, Nagai K, Kamihira S, Tomonaga M, Yanagihara K, Miyazaki Y. Itonaga H, et al. Among authors: doi y. Leuk Res. 2014 Jan;38(1):76-83. doi: 10.1016/j.leukres.2013.10.022. Epub 2013 Nov 5. Leuk Res. 2014. PMID: 24262285 Free article.

5

High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders.

Sasaki D, Doi Y, Hasegawa H, Yanagihara K, Tsukasaki K, Iwanaga M, Yamada Y, Watanabe T, Kamihira S. Sasaki D, et al. Among authors: doi y. Virol J. 2010 Apr 28;7:81. doi: 10.1186/1743-422X-7-81. Virol J. 2010. PMID: 20423527 Free PMC article.

6

Structural insights into catalytic promiscuity of chalcone synthase from Glycine max (L.) Merr.: Coenzyme A-induced alteration of product specificity.

Waki T, Imaizumi R, Uno K, Doi Y, Tsunashima M, Yamada S, Mameda R, Nakata S, Yanai T, Takeshita K, Sakai N, Kataoka K, Yamamoto M, Takahashi S, Nakayama T, Yamashita S. Waki T, et al. Among authors: doi y. Biochem Biophys Res Commun. 2024 May 8;718:150080. doi: 10.1016/j.bbrc.2024.150080. Online ahead of print. Biochem Biophys Res Commun. 2024. PMID: 38735137

7

Period prevalence of uveitis in human T-lymphotropic virus 1 carriers versus noncarriers in a highly endemic area: The Nagasaki Islands Study.

Miyata J, Yamanashi H, Dake Y, Nobusue K, Doi Y, Honda Y, Nonaka F, Arima K, Tamai M, Sasaki D, Shimizu Y, Hasegawa H, Kitaoka T, Yanagihara K, Aoyagi K, Kawakami A, Maeda T. Miyata J, et al. Among authors: doi y. J Med Virol. 2024 May;96(5):e29653. doi: 10.1002/jmv.29653. J Med Virol. 2024. PMID: 38712746

8

Temporal and fertilizer-dependent dynamics of soil bacterial communities in buckwheat fields under long-term management.

Morigasaki S, Matsui M, Ohtsu I, Doi Y, Kawano Y, Nakai R, Iwasaki W, Hayashi H, Takaya N. Morigasaki S, et al. Among authors: doi y. Sci Rep. 2024 Apr 30;14(1):9896. doi: 10.1038/s41598-024-60655-w. Sci Rep. 2024. PMID: 38688974 Free PMC article.

9

Ligand-based virtual-screening identified a novel CFTR ligand which improves the defective cell surface expression of misfolded ABC transporters.

Taniguchi S, Berenger F, Doi Y, Mimura A, Yamanishi Y, Okiyoneda T. Taniguchi S, et al. Among authors: doi y. Front Pharmacol. 2024 Apr 11;15:1370676. doi: 10.3389/fphar.2024.1370676. eCollection 2024. Front Pharmacol. 2024. PMID: 38666024 Free PMC article.

10

Pseudomonas aeruginosa Lipid A Structural Variants Induce Altered Immune Responses.

Hofstaedter CE, O'Keefe IP, Met CM, Wu L, Vanderwoude J, Shin S, Diggle SP, Riquelme SA, Rasko DA, Doi Y, Harro JM, Kopp BT, Ernst RK. Hofstaedter CE, et al. Among authors: doi y. Am J Respir Cell Mol Biol. 2024 Apr 24. doi: 10.1165/rcmb.2024-0059OC. Online ahead of print. Am J Respir Cell Mol Biol. 2024. PMID: 38656811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,073 results

Search Page